Drug Profile
CRx 189
Latest Information Update: 04 Aug 2005
Price :
$50
*
At a glance
- Originator CombinatoRx
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory bowel diseases
Most Recent Events
- 04 Aug 2005 No development reported - Preclinical for Inflammatory bowel disease in USA (unspecified route)
- 30 Mar 2004 Preclinical trials in Inflammatory bowel disease in USA (unspecified route)